Michael Hakes - CFA, MBA

Investors should be weary as markets could be choppy going into Q4.
Lots of pressure on consumers with slowing retail sales.
Student load payments & mortgage renewals weighing on economy. 
Soft landing of the economy not a guarantee.
High energy prices expected to remain as Saudi manipulates markets.

Stress on consumers will benefit low cost retailers. 
$100 billion in sales very strong base.
Margins improving as supply chain difficulties improve.
Current share price a good place to buy.

Current share price a good place to buy.
Investment banking & wealth management business units expected to improve.
Expecting ~$100 share price going forward.
Comfortable with management team.
Good long term investment.

Spend the last ~20 years consolidating scientific/diagnostics tools market.
Very strong demand for health care products.
Strong pipeline of R&D.
Expecting a 5-7% revenue growth & double digit earnings growth.
Great compounding business for long term shareholder.

(A Top Pick Dec 07/22, Down 54%)

Disappointing for short term investors.
Two quarters of missed earnings.
Too much inventory on hand.
Second distribution center very expensive.
Assuming no recession, expecting further growth.
Optimistic and looking at a improved share price in 2024.
Would recommend buying shares at this price.

Share price flat.
Flat revenues accounting for slow share price growth.
Chip supply to automotive industry expected to lift earnings. 
Will continue to hold shares.
Overall trend of demand for chips expected to be good for the business. 

Beneficiary of obesity drug development.
Healthcare sector growing. 
Demand for obesity reduction growing.
Selling on strength, but still owns shares.

International sports betting & gaming business (Poker Stars etc.).
$12 billion in revenues.
Total market for sports betting and gaming is growing.
Market share difficult to gain.
Challenging business model with uncertain regulation.
Consumer protection regulation & money laundering also a concern.
Would not recommend investing. 

Performs well during strong economic environment.
Infrastructure spending in USA rising.
Union negotiations rising costs for company.
New CEO good for business.
Overall is a strong business for the long term investor.
Below $200/share a good place to buy.

Share price too high - displaying signs of exuberance.
Selling at current share price.
Uranium price at 12 year high.
Demand for nuclear energy rising.

Vaccine discoveries good for business.
Does not own shares at this time.
Market for pharmaceuticals separating between strong and weak players.
Current share price fairly valued.

Owns shares for past 5 years.
Move to cashless society good for business.
Recovery in global travel helping with revenue.
Good business for long term shareholders.
Expecting double digit earnings growth.
Current share price not cheap.
Excellent management team.

Business has become profitable recently.
Current share price not cheap.
Business losing market share, but strong technology.
Would buy shares below $100/share.

Over investment in warehousing starting to recede.
Growing into storage space.
AWS business growing strongly.
Good for long term investor.
Strong franchise.
Excellent management team.

Owns shares in the company.
Very strong business.
Automotive supply demand rising. 
Electric vehicle transition very good for business.
Expecting share price to rise to $100 in the next 18-24 months.
Good for long term investors.